News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Earnings
Endocyte, Inc. (ECYT) Reports Second Quarter Financial Results And Provides Clinical Update 7/30/2014
MacroGenics, Inc. (MGNX) Announces Date Of Second Quarter 2014 Financial Results Conference Call 7/30/2014
ReVance Therapeutics, Inc. (RVNC) To Release Second Quarter 2014 Financial Results And Host Conference Call On Tuesday, August 12, 2014 7/30/2014
Cempra, Inc. Reports Second Quarter 2014 Financial And Operating Results 7/30/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Second-Quarter 2014 Financial Results 7/30/2014
Guerbet (GBT): 2014 First-Half Results 7/30/2014
Almirall's H1 Results 2014: Continued Growth Acceleration 7/30/2014
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 7/30/2014
Discovery Laboratories (DSCO) To Report 2014 Second Quarter Financial Results And Hold Conference Call On Tuesday, August 5, 2014 At 9:00 A.M. Eastern Time 7/30/2014
Cambrex Corporation (CBM) To Announce Second Quarter 2014 Financial Results On August 1, 2014 7/30/2014
ImmunoCellular Therapeutics, Ltd (IMUC) To Report Financial Results For The Second Quarter 2014 On August 7, 2014 7/30/2014
Covance Inc. (CVD) Reports Second Quarter Net Revenue Growth Of 8.0% To $639 Million, Pro Forma EPS Growth Of 21.5% To $0.95 And Adjusted Net Orders Of $773 Million 7/30/2014
Landauer (LDR) Sets Date And Time For Announcement Of Fiscal Third Quarter 2014 Results 7/30/2014
Regado Biosciences, Inc. (RGDO) To Provide Second Quarter 2014 Financial Results And Corporate Highlights 7/30/2014
GW Pharmaceuticals To Report Q3 2014 Financial Results And Host Conference Call On 6 August, 2014 7/30/2014
Covance Inc. (CVD) Invites You To Join The Webcast Of Its Second Quarter 2014 Financial Results Conference Call 7/30/2014
Hospira, Inc. Reports Second-Quarter 2014 Results 7/30/2014
Geron Corporation (GERN) Announces Conference Call To Discuss Second Quarter 2014 Financial Results 7/30/2014
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program 7/30/2014
BioLineRx Ltd. To Report Second Quarter 2014 Results On August 6, 2014 7/30/2014
Dyax Corp. (DYAX) Announces Second Quarter 2014 Financial Results 7/30/2014
Vertex Pharmaceuticals Incorporated (VRTX) Reports Second Quarter 2014 Financial Results And Provides Updates On Key Research And Development Programs 7/30/2014
ICON Reports Second Quarter 2014 And Increases Earnings Guidance 7/30/2014
Evoke Pharma, Inc. Schedules Webcast And Conference Call For Second Quarter 2014 Financial Results 7/30/2014
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014
Genocea Biosciences To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Q1 FY15 Financial Results 7/30/2014
Targacept, Inc. (TRGT) To Report Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014
Sorin Group S.p.A. (SRN) Announces Results For The Second Quarter Of 2014 7/30/2014
Eagle Pharmaceuticals (EGRX) Schedules Third Quarter Earnings Release And Conference Call 7/30/2014
Evogene Ltd. (EVGN)’s Second Quarter 2014 Earnings Announcement Schedule 7/30/2014
Five Prime Therapeutics, Inc. (FPRX) To Announce Second Quarter Financial Results And Host Conference Call On August 5, 2014 7/30/2014
BioTie Therapies Corp. Interim Report 1 January - 30 June 2014 7/30/2014
XOMA (US) LLC (XOMA) To Announce Second Quarter 2014 Financial Results And Host Webcast On August 7 7/30/2014
Portola Pharmaceuticals, Inc. To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014 7/30/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Second Quarter 2014 Financial Results 7/30/2014
Celladon Corporation To Report Second Quarter 2014 Results On August 7, 2014 7/30/2014
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Second Quarter 2014 Financial Results On August 6, 2014 7/30/2014
Pain Therapeutics (PTIE) To Host Conference Call To Discuss Q2 2014 Financial Results 7/30/2014
Horizon Pharma To Host Conference Call And Webcast To Discuss Second Quarter 2014 Financial Results On August 7, 2014 7/30/2014
INSYS Therapeutics To Report Second Quarter 2014 Results 7/30/2014
Merck & Co., Inc. (MRK) Second Quarter Profit More Than Doubles As Newer Drugs Offset Generics 7/29/2014
Flamel Technologies (FLML) Announces Second Quarter Of Fiscal Year 2014 Results 7/29/2014
Pfizer Inc. (PFE)'s Need For A Deal Looms Larger As Second Quarter Profits Sinks 79 Percent 7/29/2014
Raptor Pharmaceutical Inc. (RPTP) To Hold Second Quarter 2014 Financial Results Webcast And Conference Call 7/29/2014
Innophos Holdings, Inc. Reports Second Quarter 2014 Results 7/29/2014
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Second Quarter Financial Results And Operational Update 7/29/2014
Pharmacyclics, Inc. (PCYC) Announces Date Of Conference Call To Discuss Financial Results For Second Quarter Of 2014 7/29/2014
United Therapeutics Corporation (UTHR) Reports Second Quarter 2014 Financial Results 7/29/2014
Ambit Biosciences To Announce Second Quarter 2014 Financial Results 7/29/2014
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On August 5th To Discuss Second Quarter 2014 Financial Results And Recent Highlights 7/29/2014
Alder Biopharmaceuticals Inc. To Host Conference Call To Discuss Second Quarter 2014 Financial And Operating Results 7/29/2014
China Biologic Products To Report Second Quarter 2014 Financial Results 7/29/2014
ACADIA Pharmaceuticals, Inc. (ACAD) To Announce Second Quarter 2014 Financial Results On August 5, 2014 7/29/2014
Egalet To Host Conference Call And Webcast To Discuss Second Quarter Financial Results On August 12, 2014 7/29/2014
Antibe Therapeutics Inc. Reports Year-End Financial And Operating Results 7/29/2014
Compugen Ltd. (CGEN) Second Quarter 2014 Conference Call Scheduled For Tuesday, August 5, 2014 At 10:00 AM EDT 7/29/2014
Ophthotech Corporation (OPHT) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014 7/29/2014
Oxygen Biotherapeutics, Inc. (OXBT) Announces Fiscal Year 2014 Financial Results 7/29/2014
NPS Pharmaceuticals, Inc. (NPSP) To Report Second Quarter 2014 Financial Results 7/29/2014
ArQule, Inc. (ARQL) To Report Second Quarter 2014 Financial Results On August 5, 2014 7/29/2014
Eleven Biotherapeutics (EBIO) To Present At Wedbush 2014 Life Sciences Management Access Conference 7/29/2014
Navidea Biopharmaceuticals (NAVB) To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/29/2014
Merck & Co., Inc. (MRK) Announces Second-Quarter 2014 Financial Results 7/29/2014
Supernus Pharmaceuticals (SUPN) To Host Second Quarter 2014 Earnings Conference Call 7/29/2014
Trinity Biotech (TRIB) Announces Quarter 2 Financial Results; 25 Percent Increase In Operating Profits 7/29/2014
Array BioPharma, Inc. (ARRY) To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014 7/28/2014
Psychemedics Corporation (PMD) Announces Record Revenues 7/28/2014
Amgen (AMGN) Announces 2014 Third Quarter Dividend 7/28/2014
Rockwell Medical (RMTI) Schedules 2nd Quarter 2014 Investor Conference Call 7/28/2014
Agios Pharmaceuticals (AGIO) To Webcast Conference Call Of Second Quarter 2014 Financial Results On August 7, 2014 7/28/2014
Repligen Corporation (RGEN) To Report Second Quarter 2014 Financial Results 7/28/2014
Depomed, Inc. (DEPO) To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 7/28/2014
CTI BioPharma To Report Second Quarter 2014 Financial Results On August 4, 2014 7/28/2014
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' Second Quarter 2014 Financial Results Conference Call 7/28/2014
PDL BioPharma, Inc. (PDLI) To Announce Second Quarter 2014 Financial Results On August 11, 2014 7/28/2014
InterMune, Inc. (ITMN) To Release Second Quarter Financial Results On August 6 7/28/2014
ANI Pharmaceuticals, Inc. Schedules Conference Call For Second Quarter 2014 Financial Results 7/28/2014
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Third Quarter Financial Results And Conference Call 7/28/2014
Epizyme (EPZM) To Report Second Quarter Financial Results And Provide Corporate Update On August 13, 2014 7/28/2014
4 Ways Gilead Sciences, Inc. (GILD)’s Earnings Will Impact Every American 7/25/2014
Pacific Biosciences (PACB) Reports Second Quarter 2014 Financial Results 7/25/2014
Tesaro, Inc. (TSRO) Announces Second-Quarter 2014 Operating Results 7/25/2014
Enzymotec To Report Second Quarter Fiscal Year 2014 Financial Results 7/25/2014
AMAG Pharmaceuticals, Inc. (AMAG) To Host Conference Call On July 29, 2014 At 8:00 A.M. ET To Discuss Financial Results For The Quarter And Six Months Ended June 30, 2014 7/25/2014
Alimera Sciences (ALIM) To Release Second Quarter 2014 Results 7/25/2014
Amgen (AMGN) Announces Webcast Of 2014 Second Quarter Financial Results 7/25/2014
Champions Oncology, Inc. (CSBR) Reports Results For Quarter And Full Year Ended April 30, 2014 7/25/2014
Omnicell To Release Second Quarter 2014 Earnings Results On July 31 7/25/2014
IGI Laboratories, Inc. Announces Second Quarter 2014 Results 7/25/2014
IRIDEX Corporation (IRIX) Announces Second Quarter 2014 Conference Call And Release Date 7/25/2014
Sinovac Biotech Ltd. (SVA) To Host Conference Call To Report Second Quarter 2014 Unaudited Financial Results 7/25/2014
IDEXX Laboratories, Inc. (IDXX) Announces Second Quarter Results 7/25/2014
AbbVie (ABBV) Reports Second-Quarter 2014 Financial Results 7/25/2014
Galmed Pharmaceuticals Reports First Half 2014 Financial Results 7/25/2014
Alkermes plc (ALKS) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014
Dicerna Pharmaceuticals (DRNA) To Announce Second-Quarter 2014 Financial Results And Host Conference Call On August 7, 2014 7/25/2014
Acura Pharmaceuticals, Inc. (ACUR) To Host Second Quarter 2014 Financial Results Conference Call On August 5, 2014 7/25/2014
Pernix Therapeutics, Inc. (PTX) To Report Second Quarter 2014 Financial Results On August 11, 2014 7/25/2014
Medivation, Inc. (MDVN) Announces Second Quarter 2014 Financial Results Teleconference On August 7, 2014 7/25/2014
Sensient Technologies Corporation Declares Dividend 7/25/2014
Pozen, Inc. (POZN) Announces August 7th Webcast Of Second Quarter 2014 Results 7/25/2014
Sensient Technologies Corporation Reports Results For The Quarter Ended June 30, 2014 7/25/2014
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend 7/25/2014
Simulations Plus (SLP) Announces Quarterly Cash Dividend 7/25/2014
GlaxoSmithKline (GSK) CEO And CFO Interviewed On Q2 2014 Results And Strategy Update 7/24/2014
GlaxoSmithKline (GSK) CEO Has Bigger Problem Than China As Sales Drop 7/24/2014
Hepatitis B Drug Rockets Gilead Sciences, Inc. (GILD) Into The Big Leagues 7/24/2014
Roche (RHHBY) Profit Dented On Diagnostics Writedown 7/24/2014
Adocia Reports Operational And Financial Results For The First Half Of 2014 7/24/2014
Salix Pharmaceuticals, Ltd. (SLXP) Announces 2Q2014 Financial Results Conference Call And Webcast 7/24/2014
Gilead Sciences, Inc. (GILD) Announces Second Quarter 2014 Financial Results 7/24/2014
Clinigen Group Release: Year End Trading Update 7/24/2014
Amgen (AMGN) Growth In Brazil Picks Up, Eyes Doubling Portfolio By 2020 7/24/2014
Ligand Pharmaceuticals Inc. (LGND) Partner GlaxoSmithKline (GSK) Announces Record Quarterly Promacta™/Revolade™ Revenue Of $92 Million 7/24/2014
OXiGENE (OXGN) Announces Second Quarter 2014 Earnings Conference Call And Webcast 7/24/2014
Beximco Pharmaceuticals Half Year Results - 2014 7/24/2014
Centene Corporation Reports 2014 Second Quarter Results & Raises Guidance 7/24/2014
Sangamo BioSciences, Inc. (SGMO) Reports Second Quarter 2014 Financial Results 7/24/2014
Eli Lilly and Company (LLY) Reports Second-Quarter 2014 Results 7/24/2014
Vical Incorporated (VICL) Announces News Release And Conference Call Schedule For Second Quarter 2014 Financial Results 7/24/2014
CryoLife, Inc. (CRY) Second Quarter 2014 Revenues Increase 3 Percent To A Record $34.7 Million 7/24/2014
West Pharmaceutical Services To Host Second Quarter 2014 Conference Call 7/24/2014
OncoGenex Pharmaceuticals Inc. (OGXI) To Report Financial Results For Second Quarter 2014 On August 7, 2014 7/24/2014
Xencor To Host Second Quarter 2014 Financial Results Webcast And Conference Call 7/24/2014
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Reports Record Second Quarter Financial Results 7/24/2014
BioInvent (BOVNF) Interim Report 1 January – 30 June 2014 7/24/2014
Alexion Pharmaceuticals Inc. (ALXN) Reports Second Quarter 2014 Results 7/24/2014
Acorda Therapeutics (ACOR) To Host Conference Call To Discuss Second Quarter 2014 Financial Results On July 31, 2014 7/24/2014
Agenus (AGEN) Reports Second Quarter 2014 Financial Results 7/24/2014
AmerisourceBergen Corporation (ABC) Reports Third Quarter Fiscal Year 2014 Results 7/24/2014
IMS Health Reports Second-Quarter 2014 Results 7/24/2014
Bristol-Myers Squibb Company (BMY) Reports Second Quarter 2014 Financial Results 7/24/2014
Celgene (CELG) Reports Second Quarter 2014 Operating and Financial Results 7/24/2014
Infinity Pharmaceuticals Inc. (INFI) Announces The Date Of Its Second Quarter 2014 Financial Results Conference Call And Webcast 7/24/2014
BIND Therapeutics (BIND) To Report Second Quarter 2014 Financial Results On August 7, 2014 7/24/2014
Meridian Bioscience, Inc. (VIVO) Reports Third Quarter And Nine Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance 7/24/2014
Biogen, Inc. Second Quarter 2014 Revenues Increase 40% To $2.4 Billion; Company Raises Financial Guidance For The Year 7/23/2014
Cumberland Pharmaceuticals (CPIX) To Announce Second Quarter 2014 Financial Results On August 5, 2014 7/23/2014
Fluidigm Corporation To Announce Q2 2014 Financial Results And Host Conference Call For Investors 7/23/2014
TetraPhase Pharmaceuticals To Present At Upcoming Conferences 7/23/2014
Nektar Therapeutics (CA) (NKTR) To Announce Financial Results For The Second Quarter 2014 On Thursday, July 31, 2014, After Close Of U.S.-Based Financial Markets 7/23/2014
Columbia Laboratories, Inc. (CBRX) To Discuss Second Quarter 2014 Financial Results On July 31st Conference Call 7/23/2014
Oncodesign SA: 1st Half Of 2014 7/23/2014
The Medicines Company (MDCO) Reports Second Quarter And First Half 2014 Results 7/23/2014
ChemoCentryx, Inc. (CCXI) To Hold Second Quarter 2014 Financial Results Conference Call On Tuesday, August 5, 2014 7/23/2014
Aldeyra Therapeutics (ALDX) Schedules Webcast And Conference Call For Second Quarter 2014 Financial Results 7/23/2014
RedHill Biopharma Ltd. (RDHL) Reports Results For The Second Quarter Of 2014 7/23/2014
Thermo Fisher Scientific (TMO) Reports Second Quarter 2014 Results 7/23/2014
Dr. Reddy's Laboratories, Inc. (RDY)'s to Release Q1 FY15 Results On July 30, 2014 7/23/2014
Oxygen Biotherapeutics, Inc. (OXBT) To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On July 29, 2014 7/23/2014
AbbVie (ABBV) To Host Second-Quarter Earnings Conference Call 7/23/2014
BioScrip (BIOS) To Host Second Quarter 2014 Earnings Call 7/23/2014
Cubist Pharmaceuticals, Inc. (CBST) Reports Second Quarter 2014 Financial Results 7/23/2014
Aerie Pharmaceuticals, Inc. (AERI) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014 7/23/2014
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS 7/22/2014
iCAD, Inc. (ICAD) To Host Second Quarter 2014 Financial Results Conference Call On Wednesday, July 30, 2014 7/22/2014
GTx, Inc. (GTXI) To Report Second Quarter 2014 Financial Results On August 5, 2014 7/22/2014
EXACT Sciences Corporation (EXAS) Reports Second-Quarter 2014 Financial Results 7/22/2014
Clovis Oncology (CLVS) To Announce Second Quarter 2014 Financial Results And Host Webcast Conference Call On August 7 7/22/2014
Champions Oncology, Inc. (CSBR) To Announce Fourth Quarter And Year-End Financial Results On Thursday, July 24 7/22/2014
United Therapeutics Corporation (UTHR) To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014 7/22/2014
WuXi PharmaTech Co., Ltd. Schedules Second-Quarter 2014 Earnings Release 7/22/2014
Albany Molecular Research, Inc. (AMRI) (AMRI) To Announce Second Quarter Results 7/22/2014
Semler Scientific To Report Second Quarter 2014 Financial Results And Host Conference Call On July 25, 2014 7/22/2014
Becton, Dickinson and Company (BDX) Board Declares Dividend 7/22/2014
Jazz Pharmaceuticals plc (JAZZ) To Report 2014 Second Quarter Financial Results On August 5, 2014 7/22/2014
TG Therapeutics, Inc. (MHA) Announces Second Quarter 2014 Financial Results And Business Update 7/22/2014
Bacterin Announces Preliminary Second Quarter 2014 Results 7/22/2014
MediWound (MDWD) To Host Second Quarter 2014 Financial Results Conference Call On July 31, 2014 At 8:30 A.M. 7/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Second Quarter 2014 Financial Results And Corporate Update Teleconference And Webcast On August 5 7/22/2014
Biocryst Pharmaceuticals (BCRX) To Announce Second Quarter 2014 Financial Results August 5 7/22/2014
Aegerion Pharmaceuticals, Inc. (AEGR)To Announce Second Quarter 2014 Financial Results On Tuesday, July 29 7/22/2014
XenoPort, Inc. (XNPT) To Release Second Quarter Financial Results on August 6, 2014 7/22/2014
Endocyte, Inc. (ECYT) Announces Second Quarter 2014 Earnings Conference Call 7/22/2014
Cempra, Inc. To Report Second Quarter 2014 Financial And Operating Results, And Host Conference Call And Webcast On July 29, 2014 7/22/2014
First-half Business Figures For 2014:Sartorius AG Increases Order Intake, Sales Revenue And Profit 7/22/2014
Teva Pharmaceutical Industries Limited (TEVA) To Report Second Quarter 2014 Financial Results On July 31, 2014 7/21/2014
Syneron Medical Ltd. (ELOS) To Report Second Quarter 2014 Financial Results On August 6, 2014 7/21/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Report Second Quarter 2014 Financial And Operating Results And Host Conference Call And Webcast On August 5, 2014 7/21/2014
Galmed Pharmaceuticals Second Quarter 2014 Conference Call And Webcast Scheduled For Friday, July 25, 2014 7/21/2014
Trinity Biotech plc To Announce Second Quarter Fiscal Year 2014 Financial Results 7/21/2014
Celldex Therapeutics, Inc. (CLDX) To Report Second Quarter 2014 Financial Results And Host Corporate 2014 Objectives Update Call 7/18/2014
Shire Delivers Record Quarterly Revenues And Non GAAP Diluted Earnings Per ADS Up 42%. 7/18/2014
Swedish Orphan Biovitrum Publishes Report For The Second Quarter 2014 7/18/2014
Alexza Pharmaceuticals, Inc. (ALXA) To Report 2014 Second Quarter Financial Results On Thursday, August 7, 2014 7/18/2014
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Second Quarter 2014 Financial Results On August 7, 2014 7/18/2014
IGI Laboratories, Inc. To Hold Conference Call For 2nd Quarter 2014 Results 7/18/2014
Navidea Biopharmaceuticals (NAVB) Announces 2014 Annual Meeting Results 7/18/2014
ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Fourth Quarter And Fiscal Year 2014 Financial Results 7/18/2014
Laboratory Corporation of America Holdings (LabCorp) (LH) Announces 2014 Second Quarter Results And Increases 2014 EPS Guidance 7/18/2014
Teva Pharmaceutical Industries Limited (TEVA) To Report Second Quarter 2014 Financial Results On July 31, 2014 7/18/2014
AptarGroup Declares Quarterly Dividend 7/18/2014
Allergan Inc. (AGN) Announces Quarterly Conference Call 7/18/2014
Sagent Pharmaceuticals, Inc. Sets Date And Time For Release Of Second Quarter 2014 Financial Results 7/17/2014
Tandem Diabetes Care Schedules Second Quarter 2014 Earnings Press Release And Conference Call 7/17/2014
Agenus (AGEN) To Report Second Quarter 2014 Financial Results On July 24, 2014; Conference Call To Follow 7/17/2014
Sangamo BioSciences, Inc. (SGMO) Announces Second Quarter 2014 Conference Call And Webcast 7/17/2014
NeoGenomics, Inc. (NGNM.OB) Reports Record Revenues Of $20.7 Million On 40% Test Volume Growth And Expanding Gross Margins For The Second Quarter 2014 7/17/2014



//-->